Literature DB >> 16259644

TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.

Zheng Li1, Michael P Clarke, Michael D Barker, Norman McKie.   

Abstract

Sorsby's fundus dystrophy (SFD) is a rare autosomal dominant disorder that results in degeneration of the macular region of the retina, with onset usually in the fourth to fifth decade of life. It leads to the rapid loss of central vision, often followed by further loss of peripheral vision. SFD shares several pathological features commonly found in the 'wet' or exudative form of age-related macular degeneration (AMD), the most common cause of blindness in the elderly in developed countries. These phenotypic similarities have led to SFD being proposed as an acceptable genetic model for AMD. Whereas AMD appears to have a complex aetiology, with both genetic and environmental factors playing a role, SFD has been shown to be a single-gene disorder, linked to mutations in exon 5 of the tissue inhibitor of metalloproteinases 3 (TIMP3) gene on chromosome 22q12-q13. This review confines itself to a discussion of the known biochemical properties of the wild-type and SFD TIMP3 proteins and attempts to relate these to the pathology encountered in SFD patients. We also discuss briefly how, despite the lack of inherited mutations in the structural gene, the TIMP3 protein might play a role in the onset and progression of AMD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259644     DOI: 10.1017/S1462399405010045

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  14 in total

Review 1.  The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.

Authors:  Keith Brew; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2010-01-15

2.  A Report on Molecular Diagnostic Testing for Inherited Retinal Dystrophies by Targeted Genetic Analyses.

Authors:  Hema L Ramkumar; Harini V Gudiseva; Kameron T Kishaba; John J Suk; Rohan Verma; Keerti Tadimeti; John A Thorson; Radha Ayyagari
Journal:  Genet Test Mol Biomarkers       Date:  2016-12-22

3.  A local complement response by RPE causes early-stage macular degeneration.

Authors:  Rosario Fernandez-Godino; Donita L Garland; Eric A Pierce
Journal:  Hum Mol Genet       Date:  2015-07-21       Impact factor: 6.150

4.  Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization due to Sorsby macular dystrophy.

Authors:  Kapil G Kapoor; Sophie J Bakri
Journal:  J Ocul Pharmacol Ther       Date:  2013-04-12       Impact factor: 2.671

5.  Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration.

Authors:  Daniel Ardeljan; Catherine B Meyerle; Elvira Agron; Jie Jin Wang; Paul Mitchell; Emily Y Chew; Jing Zhao; Arvydas Maminishkis; Chi-Chao Chan; Jingsheng Tuo
Journal:  Eur J Hum Genet       Date:  2013-02-20       Impact factor: 4.246

6.  S156C mutation in tissue inhibitor of metalloproteinases-3 induces increased angiogenesis.

Authors:  Jian Hua Qi; Ganying Dai; Philip Luthert; Shyam Chaurasia; Joe Hollyfield; Bernhard H F Weber; Heidi Stöhr; Bela Anand-Apte
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

7.  Timp-3 deficiency impairs cognitive function in mice.

Authors:  Yoshichika Baba; Osamu Yasuda; Yukihiro Takemura; Yasuyuki Ishikawa; Mitsuru Ohishi; Jun Iwanami; Masaki Mogi; Nobutaka Doe; Masatsugu Horiuchi; Nobuyo Maeda; Keisuke Fukuo; Hiromi Rakugi
Journal:  Lab Invest       Date:  2009-10-05       Impact factor: 5.662

8.  A high throughput screen identifies chemical modulators of the laminin-induced clustering of dystroglycan and aquaporin-4 in primary astrocytes.

Authors:  Geoffroy Noël; Sarah Stevenson; Hakima Moukhles
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

Review 9.  Genetic basis of inherited macular dystrophies and implications for stem cell therapy.

Authors:  Carla B Mellough; David H W Steel; Majlinda Lako
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

10.  Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy.

Authors:  Z Saihan; Z Li; J Rice; N A Rana; S Ramsden; P G Schlottmann; S A Jenkins; C Blyth; G C Black; N McKie; A R Webster
Journal:  Mol Vis       Date:  2009-06-15       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.